Literature DB >> 33600459

Comparative analysis of heparin affecting the biochemical properties of chicken and murine prion proteins.

Li-Juan Wang1,2, Xiao-Dan Gu1,2, Xiao-Xiao Li1,2, Liang Shen1,2, Hong-Fang Ji1,2.   

Abstract

The conversion of cellular prion protein (PrPC) to disease-provoking conformer (PrPSc) is crucial in the pathogenesis of prion diseases. Heparin has been shown to enhance mammalian prion protein misfolding. As spontaneous prion disease has not been reported in non-mammalian species, such as chicken, it is interesting to explore the influence of heparin on the conversion of chicken prion protein (ChPrP). Herein, we investigated the influences of heparin on biochemical properties of full-length recombinant ChPrP, with murine prion protein (MoPrP) as control. The results showed that at low heparin concentration (10 μg/mL), a great loss of solubility was observed for both MoPrP and ChPrP using solubility assays. In contrast, when the concentration of heparin was high (30 μg/mL), the solubility of MoPrP and ChPrP both decreased slightly. Using circular dichroism, PK digestion and transmission electron microscopy, significantly increased β-sheet content, PK resistance and size of aggregates were observed for MoPrP interacted with 30 μg/mL heparin, whereas 30 μg/mL heparin-treated ChPrP showed less PK resistance and slight increase of β-sheet structure. Therefore, heparin can induce conformational changes in both MoPrP and ChPrP and the biochemical properties of the aggregates induced by heparin could be modified by heparin concentration. These results highlight the importance of concentration of cofactors affecting PrP misfolding.

Entities:  

Year:  2021        PMID: 33600459      PMCID: PMC7891698          DOI: 10.1371/journal.pone.0247248

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  47 in total

1.  Structural changes of the prion protein in lipid membranes leading to aggregation and fibrillization.

Authors:  Jurate Kazlauskaite; Narinder Sanghera; Ian Sylvester; Catherine Vénien-Bryan; Teresa J T Pinheiro
Journal:  Biochemistry       Date:  2003-03-25       Impact factor: 3.162

Review 2.  Protein misfolding and prion diseases.

Authors:  F E Cohen
Journal:  J Mol Biol       Date:  1999-10-22       Impact factor: 5.469

Review 3.  How to study proteins by circular dichroism.

Authors:  Sharon M Kelly; Thomas J Jess; Nicholas C Price
Journal:  Biochim Biophys Acta       Date:  2005-08-10

4.  Prions and prion diseases.

Authors:  Michael Beekes
Journal:  FEBS J       Date:  2007-02       Impact factor: 5.542

5.  Why are prion diseases precluded by non-mammals?

Authors:  Hong-Fang Ji; Hong-Yu Zhang; Ling-Ling Chen
Journal:  Trends Biochem Sci       Date:  2007-04-06       Impact factor: 13.807

Review 6.  Self-propagation of pathogenic protein aggregates in neurodegenerative diseases.

Authors:  Mathias Jucker; Lary C Walker
Journal:  Nature       Date:  2013-09-05       Impact factor: 49.962

7.  Binding of bovine prion protein to heparin: a fluorescence polarization study.

Authors:  Olga Andrievskaia; Zhanna Potetinova; Aru Balachandran; Klaus Nielsen
Journal:  Arch Biochem Biophys       Date:  2007-02-23       Impact factor: 4.013

Review 8.  The potential for transmissible spongiform encephalopathies in non-ruminant livestock and fish.

Authors:  D Matthews; B C Cooke
Journal:  Rev Sci Tech       Date:  2003-04       Impact factor: 1.181

9.  Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains.

Authors:  J van Horssen; I Otte-Höller; G David; M L Maat-Schieman; L P van den Heuvel; P Wesseling; R M de Waal; M M Verbeek
Journal:  Acta Neuropathol       Date:  2001-12       Impact factor: 17.088

10.  Prion nucleation site unmasked by transient interaction with phospholipid cofactor.

Authors:  Ashley A Zurawel; Daniel J Walsh; Sean M Fortier; Tamutenda Chidawanyika; Suvrajit Sengupta; Kurt Zilm; Surachai Supattapone
Journal:  Biochemistry       Date:  2014-01-02       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.